{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:10:02Z","timestamp":1791817802559,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea","award":["HC17C0082"],"award-info":[{"award-number":["HC17C0082"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10067-019-04782-0","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T17:02:58Z","timestamp":1588698178000},"page":"3409-3416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Temporal relationship between idiopathic inflammatory myopathies and malignancies and its mortality: a nationwide population-based study"],"prefix":"10.1007","volume":"39","author":[{"given":"Yoon-Kyoung","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Young","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoungyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongmi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul Gi","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eom Ji","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Hyun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-8837","authenticated-orcid":false,"given":"Soo-Kyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"issue":"2","key":"4782_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2010.1977","volume":"305","author":"LG Rider","year":"2011","unstructured":"Rider LG, Miller FW (2011) Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA 305(2):183\u2013190","journal-title":"JAMA"},{"key":"4782_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","volume":"14","author":"IE Lundberg","year":"2018","unstructured":"Lundberg IE, de Visser M, Werth VP (2018) Classification of myositis. Nat Rev Rheumatol 14:269\u2013278","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"4782_CR3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/art.10794","volume":"47","author":"I Marie","year":"2002","unstructured":"Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF et al (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47(6):614\u2013622","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4782_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12016-015-8511-x","volume":"52","author":"E Tiniakou","year":"2017","unstructured":"Tiniakou E, Mammen AL (2017) Idiopathic inflammatory myopathies and malignancy: a comprehensive review. Clin Rev Allergy Immunol 52(1):20\u201333","journal-title":"Clin Rev Allergy Immunol"},{"key":"4782_CR5","doi-asserted-by":"publisher","first-page":"509354","DOI":"10.1155\/2013\/509354","volume":"2013","author":"P Ungprasert","year":"2013","unstructured":"Ungprasert P, Leeaphorn N, Hosiriluck N, Chaiwatcharayut W, Ammannagari N, Raddatz DA (2013) Clinical features of inflammatory myopathies and their association with malignancy: a systematic review in Asian population. ISRN Rheumatol 2013:509354","journal-title":"ISRN Rheumatol"},{"issue":"7","key":"4782_CR6","first-page":"1300","volume":"22","author":"A Airio","year":"1995","unstructured":"Airio A, Pukkala E, Isomaki H (1995) Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol 22(7):1300\u20131303","journal-title":"J Rheumatol"},{"issue":"4","key":"4782_CR7","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00296-012-2489-y","volume":"33","author":"V Limaye","year":"2013","unstructured":"Limaye V, Luke C, Tucker G, Hill C, Lester S, Blumbergs P, Roberts-Thomson P (2013) The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis. Rheumatol Int 33(4):965\u2013971","journal-title":"Rheumatol Int"},{"issue":"4","key":"4782_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1084\/jem.20041367","volume":"201","author":"L Casciola-Rosen","year":"2005","unstructured":"Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E, Corse A, Rosen A (2005) Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 201(4):591\u2013601","journal-title":"J Exp Med"},{"issue":"6","key":"4782_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2340\/00015555-1550","volume":"93","author":"A Kasuya","year":"2013","unstructured":"Kasuya A, Hamaguchi Y, Fujimoto M, Tokura Y (2013) TIF1gamma-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155\/140 autoantibody. Acta Derm Venereol 93(6):715\u2013716","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"4782_CR10","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/rheumatology\/kew215","volume":"55","author":"EH Kang","year":"2016","unstructured":"Kang EH, Lee SJ, Ascherman DP, Lee YJ, Lee EY, Lee EB, Song YW (2016) Temporal relationship between cancer and myositis identifies two distinctive subgroups of cancers: impact on cancer risk and survival in patients with myositis. Rheumatology (Oxford) 55(9):1631\u20131641","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"4782_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13075-017-1469-8","volume":"19","author":"H Yang","year":"2017","unstructured":"Yang H, Peng Q, Yin L, Li S, Shi J, Zhang Y, Lu X, Shu X, Zhang S, Wang G (2017) Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Arthritis Res Ther 19(1):259","journal-title":"Arthritis Res Ther"},{"key":"4782_CR12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1196\/annals.1361.047","volume":"1051","author":"A Ponyi","year":"2005","unstructured":"Ponyi A, Constantin T, Garami M, Andras C, Tallai B, Vancsa A et al (2005) Cancer-associated myositis: clinical features and prognostic signs. Ann N Y Acad Sci 1051:64\u201371","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"4782_CR13","first-page":"438","volume":"35","author":"C Andras","year":"2008","unstructured":"Andras C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P et al (2008) Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 35(3):438\u2013444","journal-title":"J Rheumatol"},{"issue":"11","key":"4782_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1046\/j.1365-4362.2002.01648.x","volume":"41","author":"N Wakata","year":"2002","unstructured":"Wakata N, Kurihara T, Saito E, Kinoshita M (2002) Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol 41(11):729\u2013734","journal-title":"Int J Dermatol"},{"issue":"9250","key":"4782_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet (London, England) 357(9250):96\u2013100","journal-title":"Lancet (London, England)"},{"issue":"2","key":"4782_CR16","doi-asserted-by":"publisher","first-page":"R70","DOI":"10.1186\/ar2987","volume":"12","author":"YJ Chen","year":"2010","unstructured":"Chen YJ, Wu CY, Huang YL, Wang CB, Shen JL, Chang YT (2010) Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthritis Res Ther 12(2):R70","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"4782_CR17","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3346\/jkms.2017.32.5.718","volume":"32","author":"JA Kim","year":"2017","unstructured":"Kim JA, Yoon S, Kim LY, Kim DS (2017) Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci 32(5):718\u2013728","journal-title":"J Korean Med Sci"},{"key":"4782_CR18","unstructured":"National Health Insurance Corporation HIPRI (2010) Research report on health care utilization of patients with rare and intractable disorder and improvement of individual copayment beneficiaries program for rare and intractable disorder (in Korean)"},{"issue":"7","key":"4782_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u2013347","journal-title":"N Engl J Med"},{"issue":"8","key":"4782_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403\u2013407","journal-title":"N Engl J Med"},{"issue":"1","key":"4782_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36(1):8\u201327","journal-title":"Med Care"},{"issue":"12","key":"4782_CR22","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.7314\/APJCP.2012.13.12.6163","volume":"13","author":"HJ Seo","year":"2012","unstructured":"Seo HJ, Oh IH, Yoon SJ (2012) A comparison of the cancer incidence rates between the national cancer registry and insurance claims data in Korea. Asian Pac J Cancer Prev 13(12):6163\u20136168","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"4782_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senecal JL (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 84(4):231\u2013249","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"4782_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","volume":"77","author":"GC Dobloug","year":"2018","unstructured":"Dobloug GC, Svensson J, Lundberg IE, Holmqvist M (2018) Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study. Ann Rheum Dis 77(1):40\u201347","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4782_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/08916930600622603","volume":"39","author":"C Torres","year":"2006","unstructured":"Torres C, Belmonte R, Carmona L, Gomez-Reino FJ, Galindo M, Ramos B et al (2006) Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity 39(3):205\u2013215","journal-title":"Autoimmunity"},{"issue":"3","key":"4782_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1440-1843.2011.02103.x","volume":"17","author":"F Maldonado","year":"2012","unstructured":"Maldonado F, Patel RR, Iyer VN, Yi ES, Ryu JH (2012) Are respiratory complications common causes of death in inflammatory myopathies? An autopsy study. Respirology (Carlton, Vic) 17(3):455\u2013460","journal-title":"Respirology (Carlton, Vic)"},{"issue":"3","key":"4782_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3109\/s10165-012-0673-2","volume":"23","author":"JH Woo","year":"2013","unstructured":"Woo JH, Kim YJ, Kim JJ, Choi CB, Sung YK, Kim TH, Jun JB, Bae SC, Yoo DH (2013) Mortality factors in idiopathic inflammatory myopathy: focusing on malignancy and interstitial lung disease. Mod Rheumatol 23(3):503\u2013508","journal-title":"Mod Rheumatol"},{"key":"4782_CR28","unstructured":"Registry KCC (2011) Annual report of cancer statistics in Korea in 2010. Ministry for Health and Welfare, Korean National Cancer Institute Goyang"},{"issue":"5","key":"4782_CR29","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359\u2013E386","journal-title":"Int J Cancer"},{"issue":"5","key":"4782_CR30","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/hep.29321","volume":"66","author":"J Choi","year":"2017","unstructured":"Choi J, Han S, Kim N, Lim YS (2017) Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus-endemic population. Hepatology (Baltimore, Md) 66(5):1454\u20131463","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"12","key":"4782_CR31","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1111\/imj.13556","volume":"47","author":"K Dutton","year":"2017","unstructured":"Dutton K, Soden M (2017) Malignancy screening in autoimmune myositis among Australian rheumatologists. Intern Med J 47(12):1367\u20131375","journal-title":"Intern Med J"},{"issue":"2","key":"4782_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10067-016-3453-0","volume":"36","author":"A Ceribelli","year":"2017","unstructured":"Ceribelli A, Isailovic N, De Santis M, Generali E, Fredi M, Cavazzana I et al (2017) Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis. Clin Rheumatol 36(2):469\u2013475","journal-title":"Clin Rheumatol"},{"issue":"3","key":"4782_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1212\/WNL.0000000000002863","volume":"87","author":"A Hida","year":"2016","unstructured":"Hida A, Yamashita T, Hosono Y, Inoue M, Kaida K, Kadoya M, Miwa Y, Yajima N, Maezawa R, Arai S, Kurasawa K, Ito K, Shimada H, Iwanami T, Sonoo M, Hatanaka Y, Murayama S, Uchibori A, Chiba A, Aizawa H, Momoo T, Nakae Y, Sakurai Y, Shiio Y, Hashida H, Yoshizawa T, Sakiyama Y, Oda A, Inoue K, Takeuchi S, Iwata NK, Date H, Masuda N, Mikata T, Motoyoshi Y, Uesaka Y, Maeda MH, Nakashima R, Tsuji S, Kwak S, Mimori T, Shimizu J (2016) Anti-TIF1-gamma antibody and cancer-associated myositis: a clinicohistopathologic study. Neurology 87(3):299\u2013308","journal-title":"Neurology"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04782-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-019-04782-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04782-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:55:13Z","timestamp":1659059713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-019-04782-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["4782"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04782-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]},"assertion":[{"value":"23 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was determined to be exempt from IRB review by our university hospital IRB (IRB file No. HYUH 2018-11-014) because we used existing, publicly available data and the subjects could not be directly identified or identified through identifiers linked to the subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"YKS has received research grants from Bristol-Myers Squibb, Eisai, Pfizer, and JW Pharmaceutical. HK, SC, SGI, EJC, DHY, SYJ, EJJ, and SKC have nothing to declare. All authors declare no conflict of interest on this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}